ArticleNeoplasia (New York, N.Y.)2025

Anti-PD1 prolongs the response of PI3K and farnesyl transferase inhibition in HRAS- and PIK3CA-mutant head and neck cancers.

Dinesh Babu Manikandan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.